Tilray and Curaleaf Stocks Surge Because the DEA Might Reclassify Marijuana

The Drug Enforcement Agency said it is considering reclassifying weed as a Schedule 3 drug, rather than as a Schedule 1 substance.

Related Keywords

Thailand ,Karishma Vanjani ,Joe Biden ,Us Department Of Health ,Human Services ,Drug Enforcement Agency ,Curaleaf Holdings ,Getty Images ,President Joe Biden ,Controlled Substances ,Tilray Brands ,Advisorshares Pure ,Globalx Cannabis ,Article Normal ,Agriculture ,Farming ,Horticulture ,Retail Wholesale ,Specialty Retailing ,Marijuana Growing Cultivation ,Marijuana Retailing ,Retail ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Drug Substance Use Abuse ,Political General News ,Society Community ,Crime Legal Action ,Drug Trafficking Dealing ,Marijuana Use Abuse ,Social Issues ,Trafficking Smuggling ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Marijuana ,Economy Amp Policy ,Regulation ,Tlry ,Globalx Cannabis Etf ,Spotx ,Advisorshares Pure Us Cannabis Etf ,Omsos ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Drug ,Substance Use ,Abuse ,Political ,General News ,Society ,Community ,Crime ,Legal Action ,Drug Trafficking ,Dealing ,Marijuana Use ,Trafficking ,Smuggling ,Wholesale ,Marijuana Growing ,Cultivation ,